Thermo Fisher Scientific optimizes NGS platform for COVID-19

By The Science Advisory Board staff writers

May 6, 2020 -- To expedite genomic analysis of COVID-19 resurgent strains, Thermo Fisher Scientific has optimized its Ion AmpliSeq SARS-CoV-2 research panel for use on the Ion Torrent Genexus system.

With countries beginning to ease restrictions and businesses beginning to reopen, contact tracing and epidemiological studies will be critical, according to the company. Next generation sequencing (NGS) provides scientists with a rapid high-throughput method to analyze the SARS-CoV-2 genome and trace its origin. Thermo Fisher's automated NGS system can provide results within 24 hours.

The Ion AmpliSeq SARS-CoV-2 research panel was previously designed to run on the Ion GeneStudio S5 system. Now, the company has adapted the panel for use on Genexus, which it released in November 2019. This system provides a turnkey and simple workflow, delivering a variant report in a single day with minimal hands-on time.

Thermo Fisher, Hamilton debut DNA test system
Thermo Fisher Scientific and Hamilton have launched an automated DNA sample preparation system that extracts nucleic acids from forensic samples.
Thermo Fisher set to acquire Qiagen after all in $11.5B deal
After an on-and-off courtship, Thermo Fisher Scientific announced it is set to acquire Qiagen in a deal worth $11.5 billion. The transaction will...
Thermo Fisher, NanoPin partner on infectious disease tech
Thermo Fisher Scientific will partner with infectious diseases diagnostic company NanoPin Technologies to develop workflows for liquid chromatography-mass...
Thermo Scientific launches reagent dispensers
Thermo Scientific has launched a new family of high-precision digital reagent dispensers that are designed to facilitate the miniaturization of assays...
Thermo Fisher launches new compressor-free plate sealer
Thermo Fisher Scientific has released its ALPS 5000 plate sealer and is showing the product at the 2020 Society for Laboratory Automation and Screening...

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter